Skip navigation

News & Events

Keep up to date on AgNovos events and related news

Featured posts

All Articles

AgNovos Bioscience Announces 150th Patient Enrolled in RESTORE

AgNovos Bioscience announces that more than 150 patients have been enrolled in the RESTORE randomized, controlled trial of AGN1 LOEP.

Corporate Rebranding Announcement

AgNovos Healthcare Announces Corporate Renaming as AgNovos Bioscience

AgNovos Healthcare to participate in 2022 British Orthopaedic Association Congress

AgNovos Healthcare is pleased to participate in this year’s British Orthopaedic Association Congress (BOA) from September 20-23 in Birmingham, England.

AgNovos Healthcare to Participate in German Osteology Congress (DVO)

o AgNovos Healthcare is pleased to participate in this year’s German Osteology Congress (DVO) from September 18-20 in Baden, Germany.

AgNovos Healthcare to Participate in ASBMR Conference

AgNovos Healthcare is attending this year's ASBMR conference highlighting important research on critical topics such as the drivers and dynamics of secondary fracture risk.

AgNovos Healthcare to Participate in Swiss Orthopaedics Congress

AgNovos is pleased to participate in this year’s Swiss Orthopaedics congress (SGO) from June 22-24 in Basel, Switzerland.